Tandem Diabetes Care, Inc. (FRA:TD5A)
Germany flag Germany · Delayed Price · Currency is EUR
18.57
+0.21 (1.14%)
Last updated: Nov 25, 2025, 8:04 AM CET

Tandem Diabetes Care Statistics

Total Valuation

FRA:TD5A has a market cap or net worth of EUR 1.20 billion. The enterprise value is 1.31 billion.

Market Cap1.20B
Enterprise Value 1.31B

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date Feb 26, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 67.80M
Shares Outstanding n/a
Shares Change (YoY) +2.23%
Shares Change (QoQ) +0.90%
Owned by Insiders (%) 1.07%
Owned by Institutions (%) 104.84%
Float 62.04M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.39
PB Ratio 10.56
P/TBV Ratio 10.56
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -7.57
EV / Sales 1.52
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -61.29

Financial Position

The company has a current ratio of 2.44, with a Debt / Equity ratio of 3.42.

Current Ratio 2.44
Quick Ratio 1.76
Debt / Equity 3.42
Debt / EBITDA n/a
Debt / FCF -18.08
Interest Coverage -11.31

Financial Efficiency

Return on equity (ROE) is -109.73% and return on invested capital (ROIC) is -8.36%.

Return on Equity (ROE) -109.73%
Return on Assets (ROA) -5.93%
Return on Invested Capital (ROIC) -8.36%
Return on Capital Employed (ROCE) -13.98%
Revenue Per Employee 323,874
Profits Per Employee -65,407
Employee Count2,650
Asset Turnover 1.10
Inventory Turnover 3.25

Taxes

Income Tax -1.34M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.75% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -34.75%
50-Day Moving Average 13.39
200-Day Moving Average 15.26
Relative Strength Index (RSI) 66.68
Average Volume (20 Days) 70

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.17

Income Statement

In the last 12 months, FRA:TD5A had revenue of EUR 858.27 million and -173.33 million in losses. Loss per share was -2.60.

Revenue858.27M
Gross Profit 456.84M
Operating Income -74.15M
Pretax Income -174.67M
Net Income -173.33M
EBITDA -59.30M
EBIT -74.15M
Loss Per Share -2.60
Full Income Statement

Balance Sheet

The company has 271.98 million in cash and 387.10 million in debt, giving a net cash position of -115.12 million.

Cash & Cash Equivalents 271.98M
Total Debt 387.10M
Net Cash -115.12M
Net Cash Per Share n/a
Equity (Book Value) 113.33M
Book Value Per Share 1.67
Working Capital 310.58M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.49 million and capital expenditures -13.92 million, giving a free cash flow of -21.41 million.

Operating Cash Flow -7.49M
Capital Expenditures -13.92M
Free Cash Flow -21.41M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 53.23%, with operating and profit margins of -8.64% and -20.20%.

Gross Margin 53.23%
Operating Margin -8.64%
Pretax Margin -20.35%
Profit Margin -20.20%
EBITDA Margin -6.91%
EBIT Margin -8.64%
FCF Margin n/a

Dividends & Yields

FRA:TD5A does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.23%
Shareholder Yield -2.23%
Earnings Yield -14.49%
FCF Yield -1.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 10, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date Oct 10, 2017
Split Type Reverse
Split Ratio 0.1

Scores

FRA:TD5A has an Altman Z-Score of 0.61 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.61
Piotroski F-Score 3